Aphea.Bio

Aphea.Bio develops microbial-based biological crop solutions that replace synthetic pesticides and fertilisers — biostimulants, biofungicides, bioherbicides and bioinsecticides — using its proprietary APEXbio™ platform. The technology was spun out of research at Ghent University, KU Leuven and VIB. Co-founded in 2017 by Isabel Vercauteren (CEO) and Steven Vandenabeele, the company raised a €70 M Series C in July 2023 backed by the Bill & Melinda Gates Foundation, SFPIM, BNP Paribas Fortis and Innovation Industries. In 2025 it secured a VLAIO grant to launch its TRANSCEND platform screening 5,000 proprietary microorganism candidates. Aphea.Bio holds B Corp certification and is a Ghent biotech hub anchor.